(Press-News.org) ROCKVILLE, MD – Improving the way scientists can see the microscopic structures of the brain can improve our understanding of a host of brain diseases, like Alzheimer’s or multiple sclerosis. Studying these diseases is challenging and has been limited by accuracy of available models.
To see the smallest parts of cells, scientists often use a technique called electron microscopy. Electron microscopy historically involves adding chemicals and physically cutting the tissue. However, this approach can change the way the cells and structures look, perturbing their natural state, and can limit resolution. An alternative method, called cryo-electron tomography (cryo-ET), provides clearer images of the brain's smallest parts in a more native state, however, it requires freezing. Freezing samples to cryogenic temperatures must be done carefully or ice crystals can form, disrupting the native anatomy.
But new research by Benjamin Creekmore in Yi-Wei Chang and Edward Lee’s labs at the University of Pennsylvania shows a new technique to study the human brain's ultrastructure. They will present their research at the 68th Biophysical Society Annual Meeting, to be held February 10 - 14, 2024 in Philadelphia, Pennsylvania.
Creekmore and colleagues obtained brain tissue from autopsies, flash froze it directly on special grids with liquid ethane, and used a powerful tool called a xenon plasma focused ion beam (FIB) to cut thin slices for imaging. This method allowed them to look at the brain tissue in its near-natural state without cutting with a knife blade, adding chemicals, or slower freezing, all of which can lead to changes in the structures.
“The most common way to preserve tissue at a time of autopsy is to put it in a freezer and then use it later. But letting it freeze slowly and then warming it up and then refreezing it also disturbs the tissue. Membranes break and you can lose the normal architecture,” Creekmore explained.
One surprising part of the new method is that it lets them more easily and rapidly freeze much thicker samples—in the past samples were limited to 10 microns using similar approaches. “We were able to freeze samples up to 250 microns thick without ice crystals,” Creekmore said. The process of getting thick samples ready for high-resolution imaging is much faster than with other techniques. This speed-up can allow analysis of a wider array of samples.
By applying this approach to brain tissue from individuals with Alzheimer's disease, they were able to observe intact structures within cells, such as tau fibrils, a hallmark of Alzheimer’s disease, and cellular components that try to break down these fibrils. The team also visualized and measured myelin, a sheath that’s critical for nerve function but that breaks down in certain diseases, such as multiple sclerosis.
“Techniques for imaging human tissue historically have been relatively low resolution and they disturb the native architecture. We wanted to try to come up with a way that we could model and study brain diseases in their natural context,” Creekmore said. Their innovative method provides a first glimpse into the natural state of human brain tissue, offering valuable insights into its anatomy at a high level of detail. This new method can start to provide unique information to determine disease-causing mechanisms of a broad array of brain-related diseases.
END
Using ion beams to improve brain microscopy
New research shows a technique using ion beams to better see the structures inside human brain cells, which could help our understanding of brain diseases
2024-02-10
ELSE PRESS RELEASES FROM THIS DATE:
Faster monkeypox (mpox) testing through CRISPR
2024-02-10
ROCKVILLE, MD – Mpox, formerly known as monkeypox, is a rare viral disease that is spread through physical contact between people. Currently, testing for mpox requires lab equipment and can take a few hours to get test results. But new research suggests a way for faster testing that could be done in any clinic soon.
Md. Ahasan Ahamed, a graduate student mentored by Weihua Guan at Pennsylvania State University will present this research at the 68th Biophysical Society Annual Meeting, to be held February 10 - 14, 2024 in Philadelphia, Pennsylvania.
Though mpox symptoms are generally mild with fever, rash, and swollen lymph nodes, severe cases can occur and require medical attention. ...
New method could detect early ovarian cancer from urine samples
2024-02-10
New research by Joseph Reiner and colleagues at Virginia Commonwealth University shows promise for a urine-based test for ovarian cancer. Reiner will present their research at the 68th Biophysical Society Annual Meeting, to be held February 10 - 14, 2024 in Philadelphia, Pennsylvania.
Previous research showed that there are thousands of small molecules, called peptides, in the urine of people with ovarian cancer. While it is possible to detect those molecules using certain well-established techniques, ...
Scientists find new way to roll atomically thin nanosheets into scrolls
2024-02-10
Tokyo, Japan – Researchers from Tokyo Metropolitan University have come up with a new way of rolling atomically thin sheets of atoms into “nanoscrolls.” Their unique approach uses transition metal dichalcogenide sheets with a different composition on either side, realizing a tight roll that gives scrolls down to five nanometers in diameter at the center and micrometers in length. Control over nanostructure in these scrolls promises new developments in catalysis and photovoltaic devices.
Nanotechnology is giving us new tools to control the structure of materials at ...
New test for improving population-based colorectal cancer screening
2024-02-10
New test for improving population-based colorectal cancer screening
A new stool test appears to detect colorectal cancer precursors better than the current test. This could further reduce the number of new colorectal cancer cases as well as the number of people dying from the disease. A study led by the Netherlands Cancer Institute compared both tests. The results are published today in The Lancet Oncology.
Each year worldwide, approximately 1.9 million people are diagnosed with colorectal cancer, and 935,000 people ...
Quitting smoking at any age brings big health benefits, fast: study
2024-02-09
People who quit smoking see major gains in life expectancy after just a few years, according to a new study by University of Toronto researchers at Unity Health Toronto.
The study, published in NEJM Evidence, shows that smokers who quit smoking before age 40 can expect to live almost as long as those who never smoked. Those who quit at any age return close to never-smoker survival 10 years after quitting, and about half that benefit occurs within just three years.
“Quitting smoking is ridiculously effective in reducing ...
Discoveries can be used to optimize production of annatto powder
2024-02-09
Researchers at the University of São Paulo’s Luiz de Queiroz College of Agriculture (ESALQ-USP) and the Federal University of Viçosa (UFV) in Brazil have shown for the first time that bixin or annatto powder, a carotenoid pigment extracted from the seeds of the achiote or annatto tree (Bixa orellana), is not produced only in the seeds but also in other organs, and that the process intensifies in the plant’s adult phase.
An article on the study published in the Journal of Experimental Botany, also describes genetic modifications in the species that can optimize production of the pigment, which is widely used in the food ...
Harnessing human evolution to advance precision medicine
2024-02-09
Humans are still evolving, and Tatum Simonson, PhD, founder and co-director of the Center for Physiological Genomics of Low Oxygen at University of California School of Medicine, plans to use evolution to improve healthcare for all.
Her latest research, which was published February 9, 2024 in Science Advances, reveals that a gene variant in some Andean people is associated with reduced red blood cell count at high altitude, enabling them to safely live high in the mountains in low-oxygen conditions. Simonson’s UC San Diego lab is applying those findings toward understanding whether there may be a genetic component ...
For Black patients, 'representation matters' in evaluating prostate cancer websites
2024-02-09
Waltham — February 9, 2024 — For Black men with prostate cancer, racial representation is a key factor affecting trust in websites offering information on prostate cancer, reports a study in the March issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Our study shows that representation matters to Black patients seeking prostate cancer information online," comments lead author Stacy Loeb, MD, MSc, PhD (Hon), of New York University Langone Health. "Not only does it impact trust in the information, but a lack ...
Having COVID-19 and Long COVID can impact women’s sex lives
2024-02-09
From work to school to socializing, COVID-19 has impacted just about every part of our lives—and now Boston University research has shown that also includes what happens in the bedroom. A study of more than 2,000 cisgender women found the coronavirus disease can impair sexual function, with long COVID having an especially detrimental effect.
“If you’re sick with COVID, you’re probably less interested in sex and maybe your body is less prepared to have sex,” says Amelia M. Stanton, a BU College of Arts & Sciences assistant ...
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of HCC in patients with cirrhosis
2024-02-09
“A fundamental hypothesis we sought to test was whether biomarkers from the TGF-β signaling pathway might be of novel value in risk stratification of HCC in the clinical cirrhotic setting.”
BUFFALO, NY- February 9, 2024 – A new research paper was published in Genes & Cancer on February 5, 2023, entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.”
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer worldwide but is often diagnosed at an advanced incurable stage. Yet, despite the urgent need for ...
LAST 30 PRESS RELEASES:
Lead-free alternative discovered for essential electronics component
BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders
Skin cancer cluster found in 15 Pennsylvania counties with or near farmland
For platforms using gig workers, bonuses can be a double-edged sword
Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon
New study reveals key role of inflammasome in male-biased periodontitis
MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer
Donors enable record pool of TPDA Awards to Neuroscience 2025
Society for Neuroscience announces Gold Sponsors of Neuroscience 2025
The world’s oldest RNA extracted from woolly mammoth
Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show
Reading a quantum clock costs more energy than running it, study finds
Early MMR vaccine adoption during the 2025 Texas measles outbreak
Traces of bacteria inside brain tumors may affect tumor behavior
Hypertension affects the brain much earlier than expected
Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio
Drift logs destroying intertidal ecosystems
New test could speed detection of three serious regional fungal infections
New research on AI as a diagnostic tool to be featured at AMP 2025
New test could allow for more accurate Lyme disease diagnosis
New genetic tool reveals chromosome changes linked to pregnancy loss
New research in blood cancer diagnostics to be featured at AMP 2025
Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy
Research progress on leptin in metabolic dysfunction-associated fatty liver disease
Fondazione Telethon announces CHMP positive opinion for Waskyra™, a gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS)
Vaccine Innovation Center, Korea University College of Medicine hosts an invited training program for Ethiopian Health Ministry officials
FAU study finds small group counseling helps children thrive at school
Research team uncovers overlooked layer of DNA that may shape disease risk
Study by Incheon National University could transform skin cancer detection with near-perfect accuracy
New study reveals how brain fluid flow predicts survival in glioblastoma
[Press-News.org] Using ion beams to improve brain microscopyNew research shows a technique using ion beams to better see the structures inside human brain cells, which could help our understanding of brain diseases








